Clinical Trials Browser

Phase 1/2 × OTHER × Doxycycline × Clear all

NCT05521048 2025-12-08

Doxycycline in Cutaneous Schwannoma (NF2)

Phase 1/2 Active not recruiting

Neurofibromatosis 2

NCT01590082 2020-09-02

Doxycycline, Temozolomide and Ipilimumab in Melanoma

Phase 1/2 Terminated

12 enrolled 6 charts

Melanoma